Skip to content
← Back to this collection

PUBLICATIONS · 29150421

Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2018 Jan 18
First author
Facon T

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Facon T
      type
      Author
    2. name
      Dimopoulos MA
      type
      Author
    3. name
      Dispenzieri A
      type
      Author
    4. name
      Catalano JV
      type
      Author
    5. name
      Belch A
      type
      Author
    6. name
      Cavo M
      type
      Author
    7. name
      Pinto A
      type
      Author
    8. name
      Weisel K
      type
      Author
    9. name
      Ludwig H
      type
      Author
    10. name
      Bahlis NJ
      type
      Author
    11. name
      Banos A
      type
      Author
    12. name
      Tiab M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Facon T
      type
      Author
    2. name
      Dimopoulos MA
      type
      Author
    3. name
      Dispenzieri A
      type
      Author
    4. name
      Catalano JV
      type
      Author
    5. name
      Belch A
      type
      Author
    6. name
      Cavo M
      type
      Author
    7. name
      Pinto A
      type
      Author
    8. name
      Weisel K
      type
      Author
    9. name
      Ludwig H
      type
      Author
    10. name
      Bahlis NJ
      type
      Author
    11. name
      Banos A
      type
      Author
    12. name
      Tiab M
      type
      Author
    bibliography ids
    1. nci-bib-67aa7c7e0a6e860979e2def6
    book metadata
    content sha256
    843b4c0100ed4ad932a90928c42f6b708bf73ba33dbc2aa519828f215691155e
    document type
    citation
    dois
    1. 10.1182/blood-2017-07-795047
    electronic publication date
    display
    2017 Nov 17
    precision
    day
    year
    2017
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:29150421
    immutable id
    pubmed:29150421@843b4c0100ed4ad932a90928c42f6b708bf73ba33dbc2aa519828f215691155e
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    3
    name
    Blood
    nlm unique id
    7603509
    pages
    301-310
    volume
    131
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      29150421
      provenance
      batch id
      fb25b16edcb1373b70c1
      provider
      NCBI PubMed ESummary
      record sha256
      f948acca348c2a06a04f2e28ff78addb83dd4d82b67cae4945aae8674bc35265
      response sha256
      182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
      retrieved at
      2026-09-09T23:47:28.490065+00:00
      publication date
      display
      2018 Jan 18
      precision
      day
      year
      2018
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/29150421/
      title
      Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma.

      Preserved source evidence · Not medical advice